NYSE American: OSTX
OS Therapies Inc (OSTX)
OS Therapies Inc is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker OSTX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.
Key facts
- Ticker symbol
- OSTX
- Exchange
- NYSE American
- SEC CIK
- 1795091
- Official filings
- SEC EDGAR
Research OSTX
- Profile — Business description, headquarters, subsidiaries and corporate identifiers.
- Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
- SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
- Stock Analysis — Price chart, returns, technical indicators and related companies.
- News — Latest headlines and press coverage.
- Material Contracts — Material agreements filed as exhibits to SEC reports.
- Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
- Peer Comparison — Side-by-side financial ratios against industry peers.
Frequently asked questions
What is OS Therapies Inc's stock ticker?
OS Therapies Inc trades under the ticker symbol OSTX on NYSE American. Its SEC Central Index Key (CIK) is 1795091.
Where can I read OS Therapies Inc's SEC filings?
The OSTX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports OS Therapies Inc has filed, with AI analysis. The original documents are also on SEC EDGAR.
How can I analyze OSTX's financial statements?
The OSTX Financials page shows OS Therapies Inc's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.
How does OSTX compare with its peers and the market?
The OSTX Peer Comparison page lines OS Therapies Inc up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.
For information only — not investment advice.